Mokgalaboni Kabelo, Phoswa Wendy Nokhwezi
Department of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa, Florida, South Africa.
Front Nutr. 2023 Apr 5;10:1099880. doi: 10.3389/fnut.2023.1099880. eCollection 2023.
Obesity and type 2 diabetes (T2D) are chronic conditions with detrimental impacts on the overall health of individuals. Presently, the use of pharmacological agents in obesity and T2D offers limited benefits and pose side effects. This warrant studies on remedies that are less toxic and inexpensive while effective in ameliorating secondary complications in obesity and T2D. Plant-based remedies have been explored increasingly due to their remarkable properties and safety profile. We searched for pre-clinical evidence published from inception until 2023 on PubMed, Scopus, Google, and Semantic scholar on () in both obesity and T2D. Our focus was to understand the beneficial impact of this plant-based remedy on basic glycemic, lipid, inflammatory, and biomarkers of oxidative stress. The evidence gathered in this review suggests that treatment may significantly reduce blood glucose, body weight, total cholesterol, triglycerides, and low-density lipoprotein (LDL) in concomitant with increasing high-density lipoprotein-cholesterol (HDL-c) in rodent models of obesity and T2D. Interestingly, this effect was consistent with the reduction of malonaldehyde, superoxide dismutase and catalases, tumor necrosis factor-alpha, interleukins, and leptin. Some of the mechanisms by which reduces blood glucose levels is through stimulation of insulin secretion, increasing β-cell proliferation, thus promoting insulin sensitivity; the process which is mediated by ascorbic acid present in this plant. anti-hyperlipidemia is attributable to the content of ferulic acid found in this plant, which inhibits 3-Hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase inhibitors and thus results in reduced synthesis of cholesterol and increased hepatic LDL-c receptor expression, respectively. The present review provides extensive knowledge and further highlights the potential benefits of on basic metabolic parameters, lipid profile, inflammation, and oxidative stress in rodent models of obesity and T2D.
肥胖症和2型糖尿病(T2D)是对个体整体健康有不利影响的慢性疾病。目前,在肥胖症和T2D中使用药物制剂益处有限且存在副作用。这就需要研究毒性较小、成本低廉且能有效改善肥胖症和T2D继发性并发症的治疗方法。由于植物性治疗方法具有显著特性和安全性,对其的探索越来越多。我们在PubMed、Scopus、谷歌和语义学者数据库中搜索了从创立到2023年发表的关于()在肥胖症和T2D中的临床前证据。我们的重点是了解这种植物性治疗方法对基本血糖、血脂、炎症和氧化应激生物标志物的有益影响。本综述收集的证据表明,在肥胖症和T2D的啮齿动物模型中,()治疗可能会显著降低血糖、体重、总胆固醇、甘油三酯和低密度脂蛋白(LDL),同时提高高密度脂蛋白胆固醇(HDL-c)。有趣的是,这种效果与丙二醛、超氧化物歧化酶和过氧化氢酶、肿瘤坏死因子-α、白细胞介素和瘦素的减少一致。()降低血糖水平的一些机制是通过刺激胰岛素分泌、增加β细胞增殖,从而提高胰岛素敏感性;该过程由这种植物中存在的抗坏血酸介导。()的抗高血脂作用归因于这种植物中发现的阿魏酸含量,它抑制3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶抑制剂,从而分别导致胆固醇合成减少和肝脏LDL-c受体表达增加。本综述提供了广泛的知识,并进一步强调了()对肥胖症和T2D啮齿动物模型中基本代谢参数、血脂谱、炎症和氧化应激的潜在益处。